NADINE MILLER: Open Payments
NPI 1811929870 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 7 payments from 7 companies in 2025. Trend: 2023 $103 · 2024 $245 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| BioWound Solutions, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| LEO Pharma Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: Opzelura, DUPIXENT, bio-ConneKt, Sotyktu, ADBRY, OTEZLA, NEMLUVIO.
Industry payments across MN — which companies pay providers there.
